Skip to main content
16 August 2026
15 April 2025

Amsino Expands Global Impact with New Scientific Facility in Massachusetts

Amsino has taken a significant step forward in our mission to advance healthcare worldwide. We are proud to announce the establishment of Amsino Scientific Inc., a new medical device manufacturing, research, and development facility based in Franklin, Massachusetts. This strategic expansion marks a major milestone in…

11 April 2025

Novartis Unveils Major U.S. Growth Plan, 5K+ Jobs Coming

Novartis, a leading global innovative medicines company, announced a planned $23 billion investment over 5 years in US-based infrastructure, ensuring all key Novartis medicines for US patients will be made in the United States. This commitment enables Novartis to expand on its current manufacturing, research and techn…

10 April 2025

Amcor Opens Advanced Healthcare Packaging Facility in Malaysia

Amcor a global leader in developing and producing responsible packaging solutions, today announced that it has completed construction of its advanced coating facility for healthcare packaging in Selangor, Malaysia. This state-of-the-art facility is the first in Asia to leverage cutting-edge air knife coating technolog…

04 April 2025

Boehringer Ingelheim Opens New ADC R&D Facility in Basel to Boost Oncology Innovation

NBE Therapeutics (NBE) a wholly owned subsidiary of  Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel. This milestone reinforces its commitment to innovation in oncology and strengthens its footprint in Switzerland’s biotech ecosystem. NBE Therapeutics, a Swiss biotech founded in 2012 that…

03 April 2025

Corundum Systems Biology Opens First U.S. Office in Cambridge, MA

Corundum Systems Biology (CSB), a leading investment company dedicated to advancing life-changing systems biology solutions for human health and well-being, announced the opening of its first office in the U.S. Located at CIC Cambridge, One Broadway, in Cambridge, MA, the new office brings CSB even closer to innovator…

31 March 2025

Chiesi Acquires New Manufacturing Site with €430M Investment, Creating 300 Jobs

Chiesi Group, a global biopharmaceutical company headquartered in Parma, Italy, has announced a major investment in Nerviano (Milan, Italy), with the construction of a new facility for the production of its therapeutic solutions. The project entails the revitalization of this historical production site, first establis…

Page 22 of 57